Corient Private Wealth
XERS icon

Corient Private Wealth’s Xeris Biopharma Holdings XERS Stock Holding History

Corient Private Wealth’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.46M Buy
+184,126
New +$1.18M ﹤0.01% 1579
2025
Q1 		– Sell
-25,200
Closed -$85.4K – 2461
2024
Q4 		$85.4K Hold
25,200
– – ﹤0.01% 2241
2024
Q3 		$71.8K Buy
25,200
+8,800
+54% +$22.6K ﹤0.01% 2364
2024
Q2 		$36.9K Buy
16,400
+5,400
+49% +$10.9K ﹤0.01% 2277
2024
Q1 		$24.3K Buy
+11,000
New +$28.5K ﹤0.01% 2256

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Corient Private Wealth's XERS Position: Q2 2026 in Review

Corient Private Wealth opened a new position in Xeris Biopharma Holdings (XERS) in Q2 2026: 184,126 shares worth $1.46M. The stake represents ﹤0.01% of the portfolio and ranks #1579 among its holdings. This is a return to the name: Corient Private Wealth previously reported a position in XERS as recently as Q4 2024.

Corient Private Wealth first reported a position in XERS in Q1 2024 and has held it in 5 quarters since. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Corient Private Wealth held 184,126 shares of Xeris Biopharma Holdings worth $1.46M as of Q2 2026.
  • Xeris Biopharma Holdings was a new Corient Private Wealth position in Q2 2026.
  • Xeris Biopharma Holdings made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1579 holding.
  • Corient Private Wealth first reported a position in Xeris Biopharma Holdings in Q1 2024 and has held it in 5 quarters since.
  • 240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.